Skip to main content
. 2019 Jun 7;10(3):157–164. doi: 10.14740/cr870

Table 3. Multivariable Cox Proportional Hazards Analysis of Overall Mortality After Heart Transplantation (N = 18,396).

Covariate HR 95% CI P value
Pre-transplant ICU staya 1.3 1.1, 1.5 0.007
Age group (years)
  < 1 0.8 0.6, 1.0 0.060
  2 - 11 0.6 0.5, 0.8 < 0.001
  12 - 18 0.9 0.7, 1.2 0.583
  19 - 29 1.4 1.2, 1.7 < 0.001
  30 - 39 1.1 0.9, 1.3 0.196
  40 - 49 Ref. - -
  50 - 59 1.1 0.9, 1.2 0.342
  60 - 69 1.3 1.2, 1.5 < 0.001
  ≥ 70 1.8 1.4, 2.2 < 0.001
Interaction of ICU stay with age group (years)
  < 1 0.9 0.6, 1.3 0.587
  2 - 11 0.7 0.5, 1.1 0.115
  12 - 18 0.7 0.5, 1.0 0.069
  19 - 29 0.9 0.7, 1.2 0.590
  30 - 39 0.9 0.7, 1.2 0.396
  40 - 49 Ref. - -
  50 - 59 0.9 0.7, 1.1 0.276
  60 - 69 0.9 0.7, 1.1 0.246
  ≥ 70 0.6 0.4, 1.0 0.051
Female gender 1.1 1.0, 1.2 0.015
Race
  Non-Hispanic White Ref. - -
  Non-Hispanic Black 1.5 1.4, 1.6 <0.001
  Hispanic 1.0 0.9, 1.1 0.956
  Other 1.0 0.9, 1.2 0.716
BMI category
  Underweight 1.0 0.8, 1.1 0.807
  Normal weight Ref. - -
  Overweight 1.2 1.1, 1.3 < 0.001
Indication for transplant
  Congenital heart disease Ref. - -
  Hypertrophic cardiomyopathy 0.5 0.4, 0.7 < 0.001
  Ischemic cardiomyopathy 0.8 0.7, 0.9 0.001
  Non-ischemic cardiomyopathy 0.6 0.5, 0.7 < 0.001
  Restrictive cardiomyopathy 0.8 0.6, 0.9 0.014
  Valvular heart disease 0.6 0.4, 0.7 < 0.001
  Other 0.6 0.4, 0.7 < 0.001
Mechanical ventilation 1.3 1.1, 1.5 0.002
Mechanical circulatory support
  None Ref. - -
  Extracorporeal membrane oxygenation 2.0 1.6, 2.5 < 0.001
  Ventricular assist device 1.1 1.0, 1.2 0.001
Inotrope use 1.0 0.9, 1.1 0.632
Dialysis on waitlist 1.8 1.5, 2.2 < 0.001
Bilirubin > 2 mg/dL 1.2 1.1, 1.3 < 0.001
Infection requiring IV antibiotics 1.2 1.1, 1.3 < 0.001
Allograft ischemia time (h)
  < 2 Ref. - -
  2 - 4 1.0 0.9, 1.1 0.888
  > 4 1.2 1.1, 1.4 < 0.001

aHazard ratio (HR) reflects estimate for ages 40 - 49 years. The interaction terms estimate how this HR is modified in other age groups. BMI: body mass index.